5-13913847-G-A
Variant summary
Our verdict is Pathogenic. Variant got 18 ACMG points: 18P and 0B. PVS1PM2PP5_Very_Strong
The NM_001369.3(DNAH5):c.1432C>T(p.Arg478*) variant causes a stop gained change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000124 in 1,613,368 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★★). Variant results in nonsense mediated mRNA decay.
Frequency
Consequence
NM_001369.3 stop_gained
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 18 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
DNAH5 | NM_001369.3 | c.1432C>T | p.Arg478* | stop_gained | 11/79 | ENST00000265104.5 | NP_001360.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
DNAH5 | ENST00000265104.5 | c.1432C>T | p.Arg478* | stop_gained | 11/79 | 1 | NM_001369.3 | ENSP00000265104.4 |
Frequencies
GnomAD3 genomes AF: 0.0000197 AC: 3AN: 151910Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000159 AC: 4AN: 251124Hom.: 0 AF XY: 0.0000221 AC XY: 3AN XY: 135730
GnomAD4 exome AF: 0.0000116 AC: 17AN: 1461458Hom.: 0 Cov.: 34 AF XY: 0.0000179 AC XY: 13AN XY: 727038
GnomAD4 genome AF: 0.0000197 AC: 3AN: 151910Hom.: 0 Cov.: 33 AF XY: 0.0000404 AC XY: 3AN XY: 74188
ClinVar
Submissions by phenotype
Primary ciliary dyskinesia Pathogenic:4
Pathogenic, no assertion criteria provided | clinical testing | Natera, Inc. | May 27, 2021 | - - |
Pathogenic, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Sep 21, 2023 | For these reasons, this variant has been classified as Pathogenic. ClinVar contains an entry for this variant (Variation ID: 454748). This variant has not been reported in the literature in individuals affected with DNAH5-related conditions. This variant is present in population databases (rs747900131, gnomAD 0.004%). This sequence change creates a premature translational stop signal (p.Arg478*) in the DNAH5 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in DNAH5 are known to be pathogenic (PMID: 11788826, 16627867). - |
Likely pathogenic, no assertion criteria provided | literature only | Yale Center for Mendelian Genomics, Yale University | Aug 01, 2018 | - - |
Pathogenic, criteria provided, single submitter | clinical testing | Ambry Genetics | Jun 07, 2022 | The p.R478* pathogenic mutation (also known as c.1432C>T), located in coding exon 11 of the DNAH5 gene, results from a C to T substitution at nucleotide position 1432. This changes the amino acid from an arginine to a stop codon within coding exon 11. This alteration was detected in conjunction with another DNAH5 truncating mutation in an individual diagnosed with primary ciliary dyskinesia (Davis SD et al. Am J Respir Crit Care Med, 2019 01;199:190-198). This alteration is expected to result in loss of function by premature protein truncation or nonsense-mediated mRNA decay. As such, this alteration is interpreted as a disease-causing mutation. - |
Primary ciliary dyskinesia 3 Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | 3billion | Sep 01, 2022 | The variant is observed at an extremely low frequency in the gnomAD v2.1.1 dataset (total allele frequency: 0.002%). Stop-gained (nonsense) is predicted to result in a loss or disruption of normal protein function through nonsense-mediated decay (NMD) or protein truncation. Multiple pathogenic variants are reported downstream of the variant. The variant has been reported at least twice as pathogenic without evidence for the classification (ClinVar ID: VCV000454748 / PMID: 30067075). Therefore, this variant is classified as Pathogenic according to the recommendation of ACMG/AMP guideline. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at